Global Influenza Vaccines Market was Worth US$ 3,991.4 Million, and It is Predicted to Grow at a CAGR of 4.4% from 2018 to 2026

-
Influenza Vaccines
Influenza Vaccines

The influenza virus causes a contagious respiratory ailment known as influenza. Fever, cough, muscle and joint discomfort, headache, and severe weakness are all symptoms of influenza. Influenza illness can range from mild to severe, and it can even result in death. According to the World Health Organization (WHO), influenza-related hospitalizations range from 3-5 million instances for serious illness in 2018, while influenza-related deaths range from 290 000 to 650 000.

The Influenza Vaccines Market is growing due to increasing product approval for the vaccine. The demand for improved vaccines is increasing as seasonal influenza virus outbreaks become more common. The market for influenza vaccinations is predicted to rise as the number of licensed products grows. Seqirus Vaccine Limited, for example, got FDA clearance in August 2016 for Afluria Quadrivalent, Afluria Trivalent, Flucelvax Quadrivalent in May 2016, and Fluad in November 2015. 

Increased government initiatives to lead novel vaccine research paths are also likely to drive market expansion. For example, in April 2018, the Bill and Malinda Gates Foundation and Lucy and Larry Page announced a US$ 12 million prize for researchers who can come up with new ideas for flu vaccines that are safe, effective, and inexpensive. Furthermore, the National Institute of Allergy and Infectious Diseases (NIAID) supported a universal influenza vaccine trial in May 2018. Furthermore, the Influenza Vaccines Market is growing due to a government initiative to increase vaccine availability.

In order to avoid influenza infections, vaccines are advised. Inactivated influenza vaccine, adjuvant inactivated influenza vaccine, live attenuated influenza vaccine, and recombinant influenza vaccine are all options for influenza vaccination. The increasing spread of influenza virus epidemics around the world is driving the need for effective influenza vaccination. The key aspect fueling the company's success is a strong product pipeline.

The continual evolution of the influenza virus genetic structure results in the creation of novel viruses that are immune to currently available influenza vaccinations. The Influenza Vaccines Market is projected to face significant headwinds as a result of these constantly evolving viruses. Furthermore, market growth is likely to be hampered by the high cost of vaccine development over the forecast period. Furthermore, increasing the number of strong influenza vaccine pipeline candidates is likely to support market growth. Furthermore, in May 2018, FluGen, Inc., a vaccine development business in the clinical stage, began a clinical trial for the M2SR influenza vaccine.

Comments

Post a Comment

Popular posts from this blog

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f...
Read more

Endometrial Ablation Market Analysis, Industry Scope, Global Opportunity Analysis and Forecast Till 2027

-
Image
Endometrial Ablation Market Endometrial ablation is a procedure used to treat abnormally high uterine bleeding that cannot be managed by medicine by facilitating the destruction of the endometrium, a thin layer of the uterine wall. According to the American College of Obstetrics and Gynecology, Endometrial Ablation Market is not indicated for women who have endometrial diseases, endometrial hyperplasia, uterine cancer, a recent pregnancy, and specific uterine infections (ACOG). There are various endometrial ablation procedures available, including radiofrequency, heated fluid, heated balloon, electrosurgery, freezing, and microwave ablation techniques, depending on the technique and kind of patient being treated. The easy access to recently developed sophisticated ablation technology, convenience of use, shorter treatment times, and outpatient facilities, North America dominates the Endometrial Ablation Market . Endometrial ablation devices would see a sharp rise in global adoption d...
Read more

Blowing Agents Market Top Companies, Trends & Growth Factors, and Trend Forecast to 2025

-
Image
Blowing Agents Market The Blowing Agents Market is experiencing substantial growth, driven by the expanding demand from various industries such as construction, automotive, and packaging. Blowing agents are essential in foam production processes, contributing to lightweight and energy-efficient materials. Key market players are continuously investing in research and development to introduce eco-friendly and efficient blowing agents. The rising awareness regarding environmental concerns has led to the adoption of low global warming potential (GWP) and zero ozone depletion potential (ODP) blowing agents. Additionally, stringent regulations and policies promoting sustainable manufacturing practices have further accelerated the demand for environmentally friendly blowing agents. The market is witnessing a trend toward the adoption of innovative technologies to improve production efficiency and product performance. Advanced nucleating agents and microcellular foaming technologies are enhan...
Read more